Moloney & Co. Solicitors are working with the American Law Firm of Chappel, Smith and Arden representing women who have contracted breast implant associated anaplastic large cell lymphoma (BIA/ALCL). Both firms represent clients in medical device litigation throughout Ireland and the United States and they are currently litigating some of the first BIA/ALCL claims filed in the world.
BIA/ALCL was first recognised as a distinct disease by the World Health Organisation in 2016. It is a lymphoma that originates in the breast and occurs and occurs almost exclusively in women who have received breast implants possessing a textured surface. A leading manufacturer of textured breast implants is Dublin-based Allergan Plc.
In December 2018 the French notified body for the European directives covering medical devices declined to renew the CE Certificate for Allergen textured implants and requested the company to recall all such products from French medical facilities. Allergen has since expanded its recall to all of its European countries.
Speaking about the recall Liam Moloney Solicitor said today “in 2016 over 1.5 million implant procedures were performed worldwide and many Irish women have received breast implants. The Health Products Regulatory Authority has issued a notice with regard to these Allergan textured breast implants and have advised any individual who has concerns that they may have symptoms (in particular fluid collection pain or swelling) associated with their breast implant should talk to their doctor.”
Women whom have contracted this disease may also have a separate claim against the implant manufacturer. Moloney Solicitors are happy to assist any women who may wish to investigate a civil claim and should contact Liam Moloney Solicitor (LiamMoloney@moloneysolicitors.ie) or Graham Newman Attorney at Law (gnewman@csa-law.com) for further assistance.
